A randomized double blinded sham-controlled study to determine the efficacy and safety of dexamethasone implants in chronic central serous chorioretinopathy
- Conditions
- Health Condition 1: H32- Chorioretinal disorders in diseases classified elsewhere
- Registration Number
- CTRI/2023/06/053775
- Lead Sponsor
- Hyderabad Eye Research Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Adults of both genders aged 30 years or more
2.Diagnosis of cCSC confirmed at screening visit by complete ocular examination and multimodal imaging in the study eye
3.Best corrected vision score of 73 to 19 at test distance of 4 meters on ETDRS chart at recruitment (Snellen equivalent 20/40 to 20/400)
4.Decrease in vision primarily secondary to cCSC
5.Willing to sign informed consent form before initiation of any study related procedure.
1.Patients not able to comply with the study or follow up procedures
2.Laser/ PDT treatment for CSC within 3 months of enrolment
3.Use of corticosteroids in all forms within 3 months of enrolment
4.Pharmacological treatment (eplerenone) for CSC within a month of enrolment
5.Eyes with choroidal neovascularization demonstrable on multimodal imaging (OCTA/FA/ICGA)
6.Non-study eye vision of <20/200,
7.Aphakia in study eye
8.History of glaucoma in either eye (IOP >24 mmHg)
9.Cataract grade dense enough to affect retinal imaging
10.History of hypersensitivity to fluorescein dye
11.Presence of sub-retinal fluid (SRF) or intra-retinal fluid (IRF) secondary to causes other than CSC
12.Presence of active infectious disease or intra-ocular inflammation, active or suspected periocular infection in either eye at the time of enrolment
13.History of intra-ocular surgery within 3 months in the study eye prior to the randomization
14.Pregnancy induced CSC.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method